Evidence map›Paper›PMID 32987822›Full record

ArticleJournal of clinical medicine2020

Effect of

Lorenzo Drago, Gabriele Meroni, Antonio Chiaretti, Nicola Laforgia, Salvatore Cucchiara, Maria Elisabetta Baldassarre, On Behalf Of The Surveyflor Group

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mobile Antimicrobial Resistance Genes in Probiotics.Antibiotics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Lorenzo DragoLaboratory of Clinical Microbiology and Microbial Metagenomic Unit, Department of Biomedical Sciences, University of Milan, 20133 Milan, Italy.ORCID 0000-0002-5206-540X
Gabriele MeroniLaboratory of Clinical Microbiology and Microbial Metagenomic Unit, Department of Biomedical Sciences, University of Milan, 20133 Milan, Italy.ORCID 0000-0003-2772-6410
Antonio ChiarettiPediatric Emergency Department, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Rome, 00168 Rome, Italy.ORCID 0000-0002-9971-1640
Nicola LaforgiaDepartment of Biomedical Science and Human Oncology-Section of Neonatology and NICU, University "Aldo Moro" of Bari, 70124 Bari, Italy.ORCID 0000-0002-4610-1216
Salvatore CucchiaraPediatric Gastroenterology and Liver Unit, Department of Women's and Children's Health, Sapienza University of Rome, 00161 Rome, Italy.
Maria Elisabetta BaldassarreDepartment of Biomedical Science and Human Oncology-Section of Neonatology and NICU, University "Aldo Moro" of Bari, 70124 Bari, Italy.ORCID 0000-0003-0590-6664
On Behalf Of The Surveyflor Group
University of Bari Aldo Moro · ITUniversity of Milan · ITAgostino Gemelli University Polyclinic · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics are living microorganisms, which, upon oral ingestion, may prevent antibiotic-associated diarrhea (AAD) through the normalization of an unbalanced gastrointestinal flora. The objective of this study was to evaluate the benefits of a probiotic combination (

Indexed as

antibiotic-associated diarrheaantibioticschildrenLacticaseibacillus rhamnosusLimosilactobacillus reuteriprobiotics

Identifiers

PMID32987822
PMCPMC7650601
OpenAlexW3089190088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.